Br J Cancer. 2002 Feb 1;86(3):402-8.
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.
Michalides R, van Tinteren H, Balkenende A, Vermorken JB, Benraadt J, Huldij J, van Diest P,
Division of Tumour Biology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. firstname.lastname@example.org
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1394-404.
Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.
Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY,
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung Hsien, Taiwan. email@example.com
Psychol Assess. 2004 Sep;16(3):255-66.
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples.
DuHamel KN, Ostrof J, Ashman T, Winkel G, Mundy EA, Keane TM, Morasco BJ, Vickberg SM, Hurley K, Burkhalter J, Chhabra R, Scigliano E, Papadopoulos E, Moskowitz C, Redd W,
Program for Cancer Prevention and Control, Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA. firstname.lastname@example.org
J Clin Oncol. 2005 Jan 1;23(1):175-83.
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH,
University of Wisconsin Medical School, 600 Highland Ave, K4/562, Madison, WI, USA. email@example.com
J Urol. 2005 May;173(5):1496-501.
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA,
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.